WASHINGTON, May 1 (Reuters) - The U.S. Food and Drug Administration said on Thursday that Amgen Inc and Wyeth’s Enbrel arthritis drug will carry a warning about the risk of serious infections that can lead to hospitalization or death.
WASHINGTON, May 1 (Reuters) - The U.S. Food and Drug Administration said on Thursday that Amgen Inc and Wyeth’s Enbrel arthritis drug will carry a warning about the risk of serious infections that can lead to hospitalization or death.
